Galmed Pharmaceuticals
GLMD
#10331
Rank
โ‚ฌ2.55 M
Marketcap
1,54ย โ‚ฌ
Share price
-5.62%
Change (1 day)
-60.92%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -6,48ย โ‚ฌ

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -6,14ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -9,69ย โ‚ฌ an increase over its 2021 EPS that were of -18,16ย โ‚ฌ.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-6,48ย โ‚ฌ-33.19%
2022-9,69ย โ‚ฌ-46.62%
2021-18,16ย โ‚ฌ-2.22%
2020-18,57ย โ‚ฌ39.18%
2019-13,35ย โ‚ฌ70.18%
2018-7,84ย โ‚ฌ-41.84%
2017-13,48ย โ‚ฌ-34.23%
2016-20,50ย โ‚ฌ56.84%
2015-13,07ย โ‚ฌ9.2%
2014-11,97ย โ‚ฌ-53.43%
2013-25,70ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,18ย โ‚ฌ-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,69ย โ‚ฌ-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-0,69ย โ‚ฌ-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,16ย โ‚ฌ-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA